Central India Cancer Research Institute

Nagpur 440 010

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Thyroid Cancer

Studies at this site

• Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer — Completed
• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment — Completed